Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Photomed Laser Surg ; 34(12): 631-637, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27111566

RESUMEN

OBJECTIVE: Our primary hypothesis was that red-to-near infrared (R-NIR) irradiation would have an effect on the kinetics parameters of the reaction of cytochrome c with isolated cytochrome c oxidase (CCO), and that the magnitude and direction of these changes could be interpreted in the context of the reaction schemes proposed by other authors. New values for the milimolar extinction coefficients of cytochrome c were also determined. BACKGROUND DATA: Definitive answers to the fundamental processes involved in red-to-near infrared photobiomodulation (R-NIR-PBM) have not been obtained. The consensus is that the electron transport chain enzyme CCO is the target for R-NIR-PBM. This work was undertaken to explore the effect of R-NIR on the activity of isolated CCO. METHODS: Scans for cytochrome c were obtained in both reduced and oxidized states, and values for the extinction coefficients were calculated. Activity assays were performed by following the oxidation state of cytochrome c at 550 or 415 nm. R-NIR effects on CCO activity were evaluated by pre-irradiating the enzyme at 670 or 830 nm, or by irradiating the reaction mixture with 660 nm light. RESULTS: Milimolar extinction coefficients (L-1 cm-1) were: ɛ550red = 29.1 ± 0.4, ɛ550ox = 8.60 ± 0.15, ɛ415red = 140 ± 2, and ɛ415ox = 89.0 ± 1.1. Reduced-oxidized extinction coefficients were: δɛ550red-ox = 20.5 ± 0.2, and δɛ415red-ox = 51.0 ± 2.0. The second order rate constants k' for irradiated CCO did not show a statistically significant difference from controls. CONCLUSIONS: The oxidation of cytochrome c by isolated CCO has not been shown to be affected by R-NIR irradiation, whether applied prior to or concurrently with the enzymatic assays. This lack of effect by R-NIR calls into question the CCO activity model of R-NIR photobiomodulation.


Asunto(s)
Citocromos c/efectos de la radiación , Complejo IV de Transporte de Electrones/efectos de la radiación , Rayos Infrarrojos , Citocromos c/química , Complejo IV de Transporte de Electrones/química , Oxidación-Reducción
2.
Chem Biol Interact ; 179(2-3): 304-13, 2009 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-19159621

RESUMEN

Arsenic compounds have been used as anti-cancer agents in traditional Chinese medicine. Ionizing radiation (IR) is one of the most effective tools in the clinical treatment of cancer. The induction of apoptotic cell death is a significant mechanism of tumor cells under the influence of radio-/chemotherapy, and resistance to these treatments has been linked to some cancer cell lines with a low propensity for apoptosis. A combination of different anti-tumoral treatment modalities is advantageous in limiting non-specific toxicity often observed by an exceedingly high dose of single regimen. The present study aimed at investigating the enhanced effects and mechanisms in cell cycle distribution and apoptosis of U937 cells, a human pre-monocytic leukemia cell line lacking functional p53 protein, after combination treatment with irradiation and As(2)O(3). Our results indicated that combined treatment led to activation of cdc-2, which is related to the expression of cyclin B. In addition, combined treatment increased apoptotic cell death in U937 cells, which is correlated with the induction of mitotic arrest, the increase in intracellular reactive oxygen species (ROS) generation, the decrease in B-cell leukemia/lymphoma 2 (Bcl-2) and B-cell leukemia/lymphoma XL (Bcl-XL) levels, the loss of mitochondria membrane potential, and the activation of caspase-3. We found that combining radiation and As(2)O(3) may be an effective strategy against p53-deficient leukemia cells.


Asunto(s)
Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Apoptosis/efectos de la radiación , Arsenicales/farmacología , Mitosis/efectos de los fármacos , Mitosis/efectos de la radiación , Óxidos/farmacología , Especies Reactivas de Oxígeno/metabolismo , Trióxido de Arsénico , Caspasas/metabolismo , Ciclo Celular/efectos de los fármacos , División Celular/efectos de los fármacos , División Celular/efectos de la radiación , Ciclina A/biosíntesis , Ciclina A/efectos de los fármacos , Ciclina A/efectos de la radiación , Ciclina B/biosíntesis , Ciclina B/efectos de los fármacos , Ciclina B/efectos de la radiación , Citocromos c/efectos de los fármacos , Citocromos c/metabolismo , Citocromos c/efectos de la radiación , Ensayos de Selección de Medicamentos Antitumorales , Fase G2/efectos de los fármacos , Fase G2/efectos de la radiación , Humanos , Membranas Mitocondriales/efectos de los fármacos , Membranas Mitocondriales/metabolismo , Membranas Mitocondriales/efectos de la radiación , Radiación Ionizante , Células Tumorales Cultivadas , Proteína p53 Supresora de Tumor/biosíntesis , Proteína p53 Supresora de Tumor/efectos de los fármacos , Proteína p53 Supresora de Tumor/efectos de la radiación , Células U937
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA